WallStreetZenWallStreetZen

NASDAQ: STRO
Sutro Biopharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Sutro Biopharma revenue was $102.48M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $11.6M, up 20.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, STRO annual revenue was $102.5M, with 65.2% growth year-over-year.

STRO past revenue growth

How has STRO's revenue growth performed historically?

Company
65.18%
Industry
499.16%
Market
37.07%
STRO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STRO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
STRO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

STRO revenue history

Current Revenue
$102.5M
Current Earnings
-$191.1M
Current Profit Margin
-186.5%

Be the first to know when STRO announces revenue.

STRO Revenue History By Year

STRO Yearly RevenueSTRO RevenueSTRO ChangeSTRO Revenue Growth
2025-12-31$102.48M$40.44M+65.18%
2024-12-31$62.04M-$91.69M-59.64%
2023-12-31$153.73M$85.96M+126.84%
2022-12-31$67.77M$5.89M+9.52%
2021-12-31$61.88M$19.16M+44.84%
2020-12-31$42.72M-$14.00k-0.03%
2019-12-31$42.74M$4.32M+11.24%
2018-12-31$38.42M-$13.32M-25.75%
2017-12-31$51.74M-$7.99M-13.38%
2016-12-31$59.73MN/AN/A

1 of 1

Sutro Biopharma Revenue FAQ

What was STRO's revenue last quarter?

On Invalid Date, Sutro Biopharma (NASDAQ: STRO) reported Q4 2025 revenue of $11.65 million up 21.35% year over year. In the same quarter last year, Sutro Biopharma's revenue was $14.81 million.

What was Sutro Biopharma's revenue in 2025?

Sutro Biopharma's annual revenue for the twelve months ending Dec 31, 2025 was $102.48 million, a 65.18% increase year over year.

How much does Sutro Biopharma make in a day?

Based on Sutro Biopharma annual revenue for the past five years, STRO makes an average of $245,430.14 per day.

What was Sutro Biopharma's annual revenue growth in the past year?

As of Q2 2026, Sutro Biopharma's revenue has grown 65.18% year over year. This is 433.98 percentage points lower than the US Biotechnology industry revenue growth rate of 499.16%. Sutro Biopharma's revenue in the past year totaled $102.48 million.

How much does Sutro Biopharma make in a year?

Sutro Biopharma's revenue by year for the past five years is:
  • Sutro Biopharma's revenue for the twelve months ending Dec 31, 2025 was $102.48 million, a 65.18% increase year over year.
  • Sutro Biopharma's annual revenue for Dec 31, 2024 was $62.04 million, a 59.64% decrease from 2023.
  • Sutro Biopharma's annual revenue for 2023 was $153.73 million, a 126.84% increase from 2022.
  • Sutro Biopharma's annual revenue for 2022 was $67.77 million, a 9.52% increase from 2021.
  • Sutro Biopharma's annual revenue for 2021 was $61.88 million, a 44.84% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.